CytomX Finds $20M More
South San Francisco-based biotech CytomX said this morning that it has raised $20M more, in a Series C funding round. The round was led by Pfizer Venture Investments, and also included Third Rock Ventures, Canaan Partners and the Roche Venture Fund. CytomX is developing therapeutics aimed at treating cancer tumors, and is led by Sean McCarthy.
posted on Tuesday, January 6, 2015 (Link to more information)
Related companies:
CYTOMX THERAPEUTICS LLC
Related stories:
> CytomX Therapeutics Raises $41M
> CytomX Gets $30M
> Cytomx Sees Pop In IPO
> Prismatic Finds $15M For Personalized News
> PocketMath Finds $10M
silicontap.com Home